High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS

OBJECTIVE: To evaluate the safety, efficacy, and durability of multiple sclerosis (MS) disease stabilization after high-dose immunosuppressive therapy (HDIT) and autologous hematopoietic cell transplantation (HCT). METHODS: High-Dose Immunosuppression and Autologous Transplantation for Multiple Scle...

Descripción completa

Detalles Bibliográficos
Autores principales: Nash, Richard A., Hutton, George J., Racke, Michael K., Popat, Uday, Devine, Steven M., Steinmiller, Kaitlyn C., Griffith, Linda M., Muraro, Paolo A., Openshaw, Harry, Sayre, Peter H., Stuve, Olaf, Arnold, Douglas L., Wener, Mark H., Georges, George E., Wundes, Annette, Kraft, George H., Bowen, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868/
https://www.ncbi.nlm.nih.gov/pubmed/28148635
http://dx.doi.org/10.1212/WNL.0000000000003660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868/
https://www.ncbi.nlm.nih.gov/pubmed/28148635
http://dx.doi.org/10.1212/WNL.0000000000003660

Ejemplares similares